Rosalind A. Eeles

Fulham Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 262 publications

Germline polygenic score for prostate cancer aggressiveness.

Germline polygenic score for prostate cancer aggressiveness.

Journal: medRxiv : the preprint server for health sciences

Published: May 18, 2026

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.

Journal: Hereditary cancer in clinical practice

Published: April 01, 2026

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Journal: European urology

Published: October 23, 2025

Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer.

Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer.

Journal: British journal of cancer

Published: October 07, 2025

SIGNIFIED: whole-body MRI screening in Li-Fraumeni syndrome in the UK.

SIGNIFIED: whole-body MRI screening in Li-Fraumeni syndrome in the UK.

Journal: ESMO open

Published: September 26, 2025

Li-Fraumeni Syndrome-Associated p53 Variants Disrupt Kidney and Urinary Tract Development.

Li-Fraumeni Syndrome-Associated p53 Variants Disrupt Kidney and Urinary Tract Development.

Journal: medRxiv : the preprint server for health sciences

Published: September 15, 2025

The landscape of microbial associations in human cancer.

The landscape of microbial associations in human cancer.

Journal: Science translational medicine

Published: September 03, 2025

Screening for Prostate Cancer with a Polygenic Risk Score. Reply.

Screening for Prostate Cancer with a Polygenic Risk Score. Reply.

Journal: The New England journal of medicine

Published: August 20, 2025

Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.

Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.

Journal: Genome medicine

Published: July 29, 2025

Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: July 17, 2025

Systematic review of PSA reference intervals in the gender diverse population with prostates.

Systematic review of PSA reference intervals in the gender diverse population with prostates.

Journal: BJU international

Published: June 23, 2025

A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practice.

A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practice.

Journal: Scientific reports

Published: May 29, 2025

Showing 1-12 of 262

Last Updated: 09/26/2026